Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
10.1056/NEJMe2118580 187
MS2 analysis consisted of quadrupole isolation (isolation window 0.7) of precursor ion followed by collision-induced dissociation (CID) in the ion trap (AGC 1.8E4, normalized collision energy 35%, maximum injection time 120 ms)
E.BhatnagarS.ShangJ.IlkayevaO.MynattR.et al (2014)
& Lorenzon, G
Category 1 Bulk substance the FDA considers eligible for use in compounding pending final rulemaking Generally permitted Category 2 Bulk substance the FDA has significant safety, identity, or quality concerns about Not permitted during review Category 3 Substance requiring further evaluation Case-by-case Critically, Category 1 status is not FDA approval
US$ 20.16
US$ 23.04
US$ 23.57
US$ 22.28
US$ 28.13
